Clinical Trials Directory

Trials / Unknown

UnknownNCT02545348

Use of the Sentinel Node Biopsy for Early Endometrial Cancer.

Evaluation (Good Medical Practice Evaluation) of the Use of the Sentinel Node Biopsy in Early Stage Endometrial Cancer and Its Implication on the Adjuvant Treatement and on the Outcomes of the Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This is an obstervationnal study, to evaluate the good clinical practice of the use of the sentinel node biospy in early stage endometrial cancer. The collaborating centres with the OncoGynecology board of the King Albert II Institute of the Clinique Universitaire Saint-Luc will also particpate to the trial. Sentinel node biospy is not yet validated for endometrial cancer, even if lots of leading team in the world published very good result and that the first prospectives trials are already published with also excellents results. The investigators decided then to include this practice in their institutional guideslines and also to registred the procedure.

Detailed description

All the sentinel node biopsy procedures for endometrial cancer will be record online via the REDCap tools, securized on a servor in Saint-Luc. Automatic email for the following of the patients and the post operative event will be send regularly for every patient to the physicians who include the patient. Efficacy of the technique, False negative and postive rate, modifications of the adjuvant treatement, long terme evolution and complication wil be evaluate.

Conditions

Interventions

TypeNameDescription
PROCEDURESentinel Lymph Node BiopsyFirst, the detection of the sentinel node will be preformed at the beginning of the surgery. Differents detection methods are use and the efficacy of each will be recorded. Second, dissection and extraction of the sentinel node will be performed, to send it to the frozen section examination. Third, other lymph node could be removed if the surgeon evaluate that it is feasible and necessary. In this group, the false negative rate will be also evaluate.

Timeline

Start date
2015-08-01
Primary completion
2020-08-01
Completion
2020-09-01
First posted
2015-09-09
Last updated
2019-12-16

Locations

10 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02545348. Inclusion in this directory is not an endorsement.